Head-to-head · Value Score
bmiMD vs RxSpan MD
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, RxSpan MD a 86. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#8 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameRxSpan MD
#20 · Grade A- · Great Deal
Est. first month
$194/mo
Save ~86% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 86 — an est. $99/mo first month, with no teaser step-up baked in. RxSpan MD isn't out of it: Shoppers who want a wide, doctor-fronted menu with upfront, all-inclusive pricing and nationwide coverage, and who don't mind that the lowest rate takes an annual commitment.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | RxSpan MD |
|---|---|---|
| Value Score | 89 (A) | 86 (A-) |
| Est. first month | $99/mo | $194/mo |
| Save vs brand-name | ~93% | ~86% |
| Semaglutide | $99/mo | From $194/mo |
| Tirzepatide | $139/mo | $329/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
RxSpan MD
A broad, physician-led menu — compounded and oral GLP-1 plus an advertised brand-name lane under a named plastic surgeon — with transparent, all-inclusive pricing from ~$194/mo (annual) across all 50 states.
Why it's a deal
- Available in all 50 states
- Transparent, all-inclusive published pricing — consult, medication, supplies, shipping, and support in one price; cancel or change plans anytime, with a low annual entry from ~$194/mo on compounded semaglutide
- Both injectable and a real oral (capsule) route, on compounded sema/tirz plus an advertised brand-name lane
- Physician-led by a named, board-certified founder (Dr. John Diaz, plastic surgeon); 24/7 unlimited messaging and coaching, free shipping
The fine print
- Compounded semaglutide/tirzepatide are not FDA-approved — not the same as Wegovy, Ozempic, or Zepbound
- Published pricing shown is for the compounded line — brand-name pricing isn't itemized
- Prescription isn't guaranteed — a provider reviews eligibility after checkout
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.